Literature DB >> 2939139

Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods.

M K Rozans, B R Smith, S J Burakoff, R A Miller.   

Abstract

We have applied limiting dilution methods suitable for the estimation of mitogen-reactive helper (pHTL) and cytotoxic (pCTL) T cell frequencies to the analysis of immune function in patients 1 mo to 6 yr after allogeneic bone marrow transplantation (BMT). Although the majority of these patients have regained normal levels of Leu-3+ (helper) and Leu-2+ (killer/suppressor) cells by 6 to 12 mo after BMT as assessed by cytofluorimetry, the fraction of these cells that can function in limiting dilution cultures is substantially below normal levels in nearly all patients. Although some BMT patients eventually recover normal frequencies of pCTL and pHTL, values typically remain greatly depressed even in patients transplanted as many as 4 to 6 yr previously. In contrast, recovery of precursors able to proliferate (without expressing either helper or cytotoxic function) in response to phytohemagglutinin (PHA) and interleukin 2 occurs in many patients by 1 yr after transplant. In spite of the decreased frequency of functional precursor cells found after BMT, each precursor is capable of giving rise to the same amount of function at limiting dilutions as that produced by cells from normal controls. In many BMT patients, proliferation in conventional PHA-stimulated cultures returns to near-normal levels even though precursor frequencies remain low. The limiting dilution method is sensitive to residual immune dysfunction in BMT recipients not easily quantitated by other, more conventional techniques.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939139

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Post-transplant immune recovery and the implication for infection risk.

Authors:  Michael E Trigg
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

3.  Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT.

Authors:  Allison L Bayer; Monica Jones; Jackeline Chirinos; Lesley de Armas; Taylor H Schreiber; Thomas R Malek; Robert B Levy
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

4.  Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation.

Authors:  E Vilmer; P Guglielmi; V David; G Leca; C Rabian; L Degos; M Boiron; A Bensussan
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.

Authors:  M Izquierdo; M A Balboa; J M Fernández-Rañada; A Figuera; A Torres; A Iriondo; M López-Botet
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

6.  Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.

Authors:  Jing Sun; Qulu Zheng; Vithal Madhira; Amy L Olex; Alfred J Anzalone; Amanda Vinson; Jasvinder A Singh; Evan French; Alison G Abraham; Jomol Mathew; Nasia Safdar; Gaurav Agarwal; Kathryn C Fitzgerald; Namrata Singh; Umit Topaloglu; Christopher G Chute; Roslyn B Mannon; Gregory D Kirk; Rena C Patel
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

7.  Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients.

Authors:  M A Balboa; M Izquierdo; F Sánchez-Madrid; J M Fernández-Rañada; M López-Botet
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

8.  The effect of graft-versus-host disease on T cell production and homeostasis.

Authors:  G Dulude; D C Roy; C Perreault
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

9.  Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.

Authors:  Ruishu Deng; Christian Hurtz; Qingxiao Song; Chanyu Yue; Gang Xiao; Hua Yu; Xiwei Wu; Markus Muschen; Stephen Forman; Paul J Martin; Defu Zeng
Journal:  Nat Commun       Date:  2017-10-17       Impact factor: 14.919

10.  Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.

Authors:  L R Gottschalk; D M Giannola; S G Emerson
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.